与伊弗梅克丁相关的化合物莫克西德克丁可以准阿皮复合物进口蛋白,并限制疟疾寄生虫的生长
Sujata B Walunj1,2, Geetanjali Mishra2, Kylie M Wagstaff1
1Nuclear Signaling Laboratory, Monash Biomedicine Discovery Institute, Department of Biochemistry and Molecular Biology, Monash University, Clayton, VIC 3800, Australia.
Cells
|January 10, 2025
概括
莫西德丁,类似于ivermectin,在寄生虫中准了importin-alpha,这些寄生虫包括Plasmodium falciparum. 这一发现表明,宏环乳是开发新抗疟疾药物的有希望的类别.
科学领域:
- 分子生物学分子生物学
- 寄生虫学的寄生虫学
- 药物发现 药物发现
背景情况:
- 通过importin超级家族蛋白质进行核运输对真核生物至关重要.
- 进口α (IMPα) 抑制剂正在作为抗感染药物对抗复杂虫寄生虫进行研究.
- 艾弗梅克丁和其他小分子抑制了Plasmodium falciparum和Toxoplasma gondii IMPα.
研究的目的:
- 调查ivermectin类似物moxidectin的抗寄生虫和IMPα向性质.
- 评估莫克西德丁作为抗疟疾药物的潜力.
主要方法:
- 循环二重化谱学检测莫克西德-IMPα结合.
- 内在的托芬光测量以确认结合和抑制.
- 在体外对抗寄生虫的测定对P. falciparum.
主要成果:
- 莫克西德直接结合于复合体IMPα.
- 在低微分子度下,莫西德丁抑制IMPα结合功能.
- 莫克西德丁在培养中表现出对P. falciparum的抗寄生虫活性.
结论:
- 莫克西德克丁显示IMPα向和抗阿皮复合体活性.
- 结果表明,针对IMPα的宏环乳具有类效应.
- 莫西德代表了一种潜在的新型抗疟疾药物,可以解决耐药性的问题.
关键词:
原菌 (Plasmodium falciparum) 是一种有毒的病毒.这种毒性淋巴细胞 (Toxoplasma gondii) 是进口的产品包括:疟疾 疟疾 是一种疾病.核传输抑制剂 核传输抑制剂毒性塑菌的发生更多相关视频
09:25CRISPR/Cas9 Gene Editing to Make Conditional Mutants of Human Malaria Parasite P. falciparum
Published on: September 18, 2018
9.9K
09:13Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
1.3K
相关概念视频
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
2.4K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.4K
01:15Anthelminthic Agents
103
Anthelmintic drugs differ significantly from antiparasitic therapies targeting protozoa, primarily due to differences in parasite biology. Whereas most protozoal treatments act on proliferating cells, anthelmintics are typically directed against mature, nonproliferative helminths. The therapeutic approach considers the helminth's reliance on neuromuscular coordination, glucose metabolism, and microtubular integrity for survival, reproduction, and localization within the host. Most anthelmintics...
103